BIAVERM
BIAVERM
Authorised
- Levamisole hydrochloride
- Niclosamide
Product identification
Medicine name:
BIAVERM
Active substance:
- Levamisole hydrochloride
- Niclosamide
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levamisole hydrochloride25.00/milligram(s)1.00Tablet
-
Niclosamide400.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AE51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Laboratoire Biard
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratoires Biove
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/5769521 9/1982
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022